Table 2 Clinical outcomes and relevant medication therapy
From: Quetiapine in refractory hyperactive and mixed intensive care delirium: a case series
Outcomes | Median pre-quetiapine days, n(range) | Median post-quetiapine days, n(range) |
|---|---|---|
Duration of refractory delirium | 15 (3 to 48) | 4 (2 to 29) |
Duration of ventilatory support | 20.5 (1 to 58) | 11 (3 to 17) |
Duration of ventilatory support since RASS score 0 achieved | - | 2 (1 to 11) |
Haloperidol n = 14 | 6 (1 to 37) | 0.5 (0 to 7) |
Lorazepam, n = 10 | 9.5 (1 to 19) | 1 (0 to 7) |
Propofol, n = 17 | 17 (5 to 27) | 6 (0 to 18) |
Opioids (fentanyl/alfentanil), n = 17 | 18 (7 to 34) | 0 (0 to 16) |
Clonidine, n = 14 | 9.5 (2 to 33) | 2 (0 to 16) |